Regencell Bioscience's Stock Surge and Wealth Collapse
Regencell Bioscience's Stock Surge and Wealth Collapse
Regencell Bioscience’s stock surged 82,000%, making CEO Yat-Gai Au briefly worth $50 billion before plummeting to $10.1 billion. Regulators in the US are investigating potential pump-and-dump schemes amid unusual trading activity and lack of profits, highlighting concerns over market manipulation and transparency.
